Skip to main content
S. 993 118th Congress Senate

Combating Illicit Xylazine Act

Official title: A bill to prohibit certain uses of xylazine, and for other purposes.

Introduced: March 28, 2023 Introduced by: Catherine Cortez Masto Democratic · Nevada See on congress.gov
Crime and Law Enforcement Congressional oversightCriminal procedure and sentencingDrug trafficking and controlled substancesManufacturing
More subjectsShow fewer subjects
Retail and wholesale tradesVeterinary medicine and animal diseases
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 11, 2024
Committee on Banking, Housing, and Urban Affairs. Hearings held.
Mar 28, 2023
Read twice and referred to the Committee on the Judiciary.
Mar 28, 2023
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action January 11, 2024

Committee on Banking, Housing, and Urban Affairs. Hearings held.

 Plain-English summary Congressional Research Service

Combating Illicit Xylazine Act

This bill criminalizes the illicit use of xylazine. (Xylazine, also known as Tranq, is a sedative that is approved for use in animals. The Drug Enforcement Administration (DEA) has reported an increase in the trafficking of fentanyl mixed with xylazine.)

Specifically, the bill establishes criminal penalties for manufacturing, distributing, or dispensing, or possessing with intent to manufacture, distribute, or dispense, xylazine for illicit use (i.e., for use in humans) in accordance with the penalties for schedule III substances (up to 10 years imprisonment or, if death or serious bodily injury occurs, up to 15 years imprisonment, as well as criminal fines).

In addition, the DEA must coordinate with the Food and Drug Administration to report on the prevalence of the illicit use of xylazine, including associated supply chains. The bill also declares the illicit use of xylazine as an emerging drug threat.

 Related & companion bills 1
  • HR 1839 Identical bill Combating Illicit Xylazine Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Lobbying activity 5

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

 Cosponsors 24
All 24 Democratic 11 Republican 13
D
Cantwell, Maria
Washington · Jan 22, 2024
 D
Blumenthal, Richard
Connecticut · Sep 26, 2023
 R
Tillis, Thomas
North Carolina · Sep 7, 2023
 D
Warner, Mark R.
Virginia · Sep 5, 2023
 D
Kaine, Tim
Virginia · Jul 27, 2023
 R
Boozman, John
Arkansas · Jul 20, 2023
 D
Luján, Ben Ray
New Mexico · Jul 20, 2023
 R
Britt, Katie Boyd
Alabama · Jul 18, 2023
 D
Rosen, Jacky
Nevada · Jul 12, 2023
 R
Young, Todd
Indiana · Jul 12, 2023
 D
Klobuchar, Amy
Minnesota · Jul 11, 2023
 R
Wicker, Roger F.
Mississippi · Jul 11, 2023
 R
Scott, Rick
Florida · Jun 15, 2023
 R
Hyde-Smith, Cindy
Mississippi · Jun 1, 2023
 R
Thune, John
South Dakota · May 30, 2023
 D
Gillibrand, Kirsten E.
New York · May 4, 2023
 R
Rounds, Mike
South Dakota · May 4, 2023
 D
Kelly, Mark
Arizona · Apr 20, 2023
 R
Capito, Shelley Moore
West Virginia · Mar 28, 2023
 R
Grassley, Chuck
Iowa · Mar 28, 2023
 D
Hassan, Margaret Wood
New Hampshire · Mar 28, 2023
 R
Marshall, Roger
Kansas · Mar 28, 2023
 R
Risch, James E.
Idaho · Mar 28, 2023
 D
Shaheen, Jeanne
New Hampshire · Mar 28, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). S. 993: Combating Illicit Xylazine Act. 118th Congress. Open America. https://openamerica.io/bill/118-S-993/
MLA
"S. 993: Combating Illicit Xylazine Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-993/.
Bluebook (legal)
S. 993, 118th Cong. (2026), https://openamerica.io/bill/118-S-993/.
Markdown link
[S. 993: Combating Illicit Xylazine Act](https://openamerica.io/bill/118-S-993/)
Report a problem